- The Wall Street Journal•7 hours ago
The maker of an EpiPen rival said its emergency allergy treatment would return to the market on Feb. 14, adding more competition to the market for the costly products.
- Reuters - UK Focus•18 hours ago
LONDON/DAVOS, Switzerland, Jan 19 (Reuters) - G laxoSmithKline's global head of pharmaceuticals, Abbas Hussain, is to leave Britain's biggest drugmaker after being passed over for the top job and will be replaced by Luke Miels from AstraZeneca. Hussain, the brother of former England cricket captain Nasser Hussain, had been a contender to take over from Chief (Taiwan OTC: 3345.TWO - news) Executive Andrew Witty, who steps down at the end of March, but the job went to GSK's consumer health boss Emma Walmsley.
- The Wall Street Journal•yesterday
Irish drugmaker Mallinckrodt and a U.S. subsidiary will pay $100 million and agree to other conditions to settle government antitrust allegations they unlawfully prevented competition for Acthar, a drug ...
SAN.PA: Summary for SANOFI - Yahoo Finance
Paris - Paris Delayed price. Currency in EUR
Add to watchlist
|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's range||75.38 - 76.69|
|52-week range||62.50 - 79.07|
|PE ratio (TTM)||23.25|
|Dividend & yield||3.35 (4.05%)|
|1y target est||N/A|